Cipla Medpro South Africa to acquire Actor Pharma
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
Subscribe To Our Newsletter & Stay Updated